RNA Interference Therapy With ARC‐520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection-Reference-Cited by-同舟云学术

RNA Interference Therapy With ARC‐520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection

Published:2020-04-23 Issue:1 Volume:72 Page:19-31
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Yuen Man‐Fung¹,Schiefke Ingolf²,Yoon Jung‐Hwan³,Ahn Sang Hoon⁴,Heo Jeong⁵,Kim Ju Hyun⁶,Lik Yuen Chan Henry⁷,Yoon Ki Tae⁸,Klinker Hartwig⁹,Manns Michael¹⁰,Petersen Joerg¹¹,Schluep Thomas¹²^ORCID,Hamilton James¹²,Given Bruce D.¹²,Ferrari Carlo¹³,Lai Ching‐Lung¹,Locarnini Stephen A.¹⁴,Gish Robert G.¹⁵

Affiliation:

1. Queen Mary Hospital The University of Hong Kong Hong Kong China

2. Eugastro Gmbh Leipzig Germany

3. Seoul National University Hospital Seoul Republic of Korea

4. Yonsei University College of Medicine Seoul Republic of Korea

5. Pusan National University and Medical Research Institute Busan Republic of Korea

6. Gachon University Gil Hospital Incheon Republic of Korea

7. The Chinese University of Hong Kong Hong Kong China

8. Pusan National University Yangsan Hospital Yangsan‐si Republic of Korea

9. Universitaetsklinikum Wuerzburg Wuerzburg Germany

10. Medizinische Hochschule Hannover Hannover Germany

11. IFI Institute at Asklepios Klinik St. Georg Hamburg Germany

12. Arrowhead Pharmaceuticals, Inc. Pasadena CA

13. Unit of Infectious Diseases and Hepatology University of Parma Parma Italy

14. Victorian Infectious Diseases Reference Laboratory Melbourne Australia

15. Division of Gastroenterology and Hepatology Department of Medicine Stanford University Medical Center Stanford CA

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31008

Reference23 articles.

1. Chronic hepatitis B: Update 2009

2. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

3. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection;European Association for the Study of the Liver;J Hepatol,2017

4. Chronic hepatitis B virus infection

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B;Annals of Hepatology;2025-01

2. Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989;Gut;2024-09-12

3. The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy;Biomarker Research;2024-08-15

4. Lipid-nanoparticle-enabled nucleic acid therapeutics for liver disorders;ACTA PHARM SIN B;2024

5. Lipid-nanoparticle-enabled nucleic acid therapeutics for liver disorders;Acta Pharmaceutica Sinica B;2024-07